IN THE NEWS
Decode Health to Sponsor ViVE 2023
Senior digital health and health IT leaders from across the U.S. will convene in Nashville, March 26-29, for ViVE 2023. This year, Decode Health is sponsoring the event as part of the Friends of Project Healthcare Pavilion.
BD and Decode Health: Innovating to bring molecular tests to patients’ homes
We’re excited to announce the BD and Decode Health strategic partnership that will accelerate innovation and advance precision medicine. Together, we’re working to advance at home collections for molecular biomarkers like RNA using a simple finger stick. Our work could unlock groundbreaking innovations for biomarker discovery and routine screening across multiple disciplines from oncology to autoimmune diseases and beyond. At-home testing can significantly improve efficiency and enhance diversity in clinical trials, speeding the development of potentially life-saving treatments.
Decode Health Recognized as the 2022 Emerging Healthcare NEXT Awards Winner
Decode Health was recently honored for its commitment to advancing precision medicine and extraordinary promise for future endeavors with a 2022 Nashville Entrepreneur Center NEXT Award for healthcare innovation.
OUR ABSTRACTS
OUR PUBLICATIONS
RECENT PODCASTS
WEBINARS
Next-generation RNA sequencing unlocks the discovery of novel candidate biomarkers for diagnostic and therapeutic applications, but reproducibility is a key challenge in biomarker discovery programs. Integrating multi-faceted quality control (QC) steps can improve design decisions and enhance the confidence and reliability of results. This webinar will demonstrate how a comprehensive QC framework supports a disease-agnostic biomarker discovery program to identify biologically relevant candidate biomarkers of complex disease and how this framework can be adapted for total RNA sequencing of whole blood, plasma, and serum samples.
